Neurol. pro Praxi, 2007; 3: 175-178

Foramen ovale patens v neurologii

MUDr. Michal Reif
I. neurologická klinika LF MU a FN u sv. Anny Brno

Foramen ovale patens (PFO, obrázek 1) se nachází přibližně u 25 % běžné populace (4). Diskutovaným se v poslední době stává fakt jeho zvýšeného výskytu u pacientů, zejména mladších 55 let, po prodělaném kryptogenním mozkovém infarktu a rovněž u pacientů trpících migrénou s aurou. Následující řádky shrnují výsledky dosavadního výzkumu zaměřeného především na kauzalitu koexistence těchto tří jednotek a z nich vycházející doporučení pro péči o takové pacienty.

Keywords: pramen ovale patens – PFO, ASA, kryptogenní iktus, mozkový infarkt, migréna, HITS

Published: August 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Reif M. Foramen ovale patens v neurologii. Neurol. praxi. 2007;8(3):175-178.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Anzola GP. Shunt-associated migraine responds favorably to atrial septal repair: a case-control study. Stroke 2006; 37: 430-4. Go to original source... Go to PubMed...
    2. Anzola GP et al. Potential source of cerebral embolism in migraine with aura: a TCD study. Neurology 1999; 52: 1622-1625. Go to original source... Go to PubMed...
    3. Anzola GP et al. TCD and risk of recurrence in patients with stroke and PFO. EJN 2003; 10: 129-35. Go to original source...
    4. Bailey ChE et al. Current management of patients with PFO and cryptogenic stroke: our experience and review of the literature.Wisconsin MJ 2004 4: 32-36.
    5. Blersch W et al.Transcranial duplex sonography in the detection of patent foramen ovale. Radiology 2002 225: 693-699. Go to original source... Go to PubMed...
    6. Diener HCH et al. Patent foramen ovale:paradoxical connection to migraine and stroke. Curr Opin Neurol 2005; 18: 299-304. Go to original source... Go to PubMed...
    7. DiTulio MR et al. PFO and risk of ischemic stroke in community - The Northern Manhattan study, Stroke 2003; 34: 1. abstract. Go to original source...
    8. Hall G et al. Triptans in migraine: the risk of stroke, cardiovascular disease and death in practice. Neurology 2004; 62: 563-68. Go to original source... Go to PubMed...
    9. Hamann GF et al. Femoral injection of echo contrast medium can increase the sensitivity of testing for PFO. Neurology 1998; 50: 1423-28. Go to original source... Go to PubMed...
    10. Homma S et al. For the PFO in the cryptogenic stroke (PICSS) investigators. Effect of medical treatment in stroke patients with PFO. Circulation 2002; 105: 2625-31. Go to original source... Go to PubMed...
    11. Homma S et al. Patent foramen ovale and stroke. Circulation 2005; 112: 1063-1072. Go to original source... Go to PubMed...
    12. Klötzsch C, Janssen G and Berlit P. TEE and contrast - TCD in the detection of a patent foramen ovale: experience with 111 patients. Neurology 1994; 9: 1603-1609. Go to original source... Go to PubMed...
    13. Meier B, Lock JE. Contemporary Management of Patent Foramen Ovale.Circulation 2003, 107: 5-9. Go to original source... Go to PubMed...
    14. Meissner I, Khanderia BK. PFO: innocent or guilty? Evidence from a prospective populationbased study. J Am Coll Cardiol 2006; 47: 440-5. Go to original source... Go to PubMed...
    15. Messé SR et al. Practice parametr: Recurrent stroke with PFO and ASA. Neurology 2004; 62: 1042-1050. Go to original source... Go to PubMed...
    16. Onorato E et al. PFO with paradoxical embolim: mid-term results of transcatheher closure in 256 patients. J Interv Card 2003; 16 (1): 43-50. Go to original source... Go to PubMed...
    17. Post M et al. Closure of a PFO is associated with decrease in prevalence of migraine. Neurology 2004; 62: 1439-1440. Go to original source... Go to PubMed...
    18. Schwerzmann M et al. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004; 62: 1399-410. Go to original source... Go to PubMed...
    19. Spencer MP et al. Power M-mode TCD for diagnosis of PFO and assessing transcatheter closure. J Neuroimaging 2004; 14: 342-349. Go to original source... Go to PubMed...
    20. Velentgas P et al. Severe vascular events in migraine patients. Headache 2004; 44: 642-651. Go to original source... Go to PubMed...
    21. Wu LA, Malouf JF. PFO in cryptogenic stroke - current understanding and management options. Arch Intern Med 2004; 164: 950-956. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.